New Treatment for Opioid-Induced Constipation

Links to Files

https://ezproxy.stevenson.edu/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=107811913&site=eds-live&scope=site

Permanent Link

http://dx.doi.org/10.1097/01.NAJ.0000459622.00045.fd
 http://hdl.handle.net/11603/5655

Collections

Stevenson University Faculty and Staff Works

Author/Creator

Author/Creator ORCID

Date

2015-01

Type of Work

journal articles
Text

Department

Sandra R. Berman School of Nursing and Health Professions

Program

Nursing

Citation of Original Publication

Aschenbrenner, D. S. (2015). New treatment for opioid-induced constipation. AJN American Journal of Nursing, 115(1), 23. doi:10.1097/01.NAJ.0000459622.00045.fd

Rights

Subjects

Abstract

The opioid antagonist naloxegol (Movantik) is now approved to treat opioid-induced constipation in adults with chronic noncancer pain. The most common adverse effects are abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache.